NEW YORK (GenomeWeb News) – Celera reported after the close of the market on Wednesday that its third-quarter revenues fell 13 percent, while its net loss rose 6 percent year over year.

The Alameda, Calif.-based molecular diagnostics firm generated revenues of $40 million for the three-month period ended Sept. 26, down from revenues of $45.8 million for the comparable period a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.